BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
213 results:

  • 1. Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.
    Santi I; Vellekoop H; M Versteegh M; A Huygens S; Dinjens WNM; Mölken MR
    Mol Diagn Ther; 2024 May; 28(3):319-328. PubMed ID: 38616205
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Stratified application of gene expression in diagnosis of thyroid nodules].
    Guan WY; Zheng JY; Nie L; Wu HY
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
    [No Abstract]    [Full Text] [Related]  

  • 3. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
    Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
    Oncotarget; 2024 Feb; 15():106-116. PubMed ID: 38329731
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Secretory Carcinoma with ETV6-ntrk3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
    Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
    Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
    Fatima S; Ahmed A; Suleman S; Din NU
    Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Salivary Gland Secretory Carcinoma; Review of 13 Years World-Wide Experience and Meta-Analysis.
    Yosefof E; Boldes T; Dan D; Robenshtok E; Strenov Y; Bachar G; Shpitzer T; Mizrachi A
    Laryngoscope; 2024 Apr; 134(4):1716-1724. PubMed ID: 37909690
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
    Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
    Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
    Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma.
    Chou A; Qiu MR; Crayton H; Wang B; Ahadi MS; Turchini J; Clarkson A; Sioson L; Sheen A; Singh N; Clifton-Bligh RJ; Robinson BG; Gild ML; Tsang V; Leong D; Sidhu SB; Sywak M; Delbridge L; Aniss A; Wright D; Graf N; Kumar A; Rathi V; Benitez-Aguirre P; Glover AR; Gill AJ
    Mod Pathol; 2023 Dec; 36(12):100329. PubMed ID: 37716505
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Secretory carcinoma of salivary glands with ntrk3 break-apart molecular rearrangement: Potential misdiagnosis with mucoepidermoid carcinoma.
    Nocini R; Sanna G; Trotolo A; Fior A; Brunelli M; Manfrin E; Favero V
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101635. PubMed ID: 37709146
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nodal Metastases Associated With Fusion Oncogenes Are Age Dependent in Young Adult Patients With Thyroid cancer.
    Li H; Han R; Meng L; Sun Y; Zhao M; Zhou W; Xie J; Yu D; Shen L; Zhou Y; Wang S; Yan J; Wang W; Ye L
    J Clin Endocrinol Metab; 2023 Dec; 109(1):143-150. PubMed ID: 37536280
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of Chimeric ntrk3 Genes in Papillary Thyroid cancer Cells by Analyzing the Imbalance of the Expression of 5' and 3' mRNA Fragments.
    Oskorbin IP; Ivanov AA; Smertina MA; Demidova IA; Boyarskikh UA; Kechin AA; Bakharev SY; Samuilenkova OV; Vihlyanov IV; Kushlinskii NE; Filipenko ML
    Bull Exp Biol Med; 2023 Jun; 175(2):239-244. PubMed ID: 37477743
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::ntrk3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.
    Klubíčková N; Mosaieby E; Ptáková N; Trinquet A; Laé M; Costes-Martineau V; Skálová A
    Virchows Arch; 2023 Aug; 483(2):187-195. PubMed ID: 37415052
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
    Hang JF; Chen JY; Kuo PC; Lai HF; Lee TL; Tai SK; Kuo CS; Chen HS; Li WS; Li CF
    Mod Pathol; 2023 Sep; 36(9):100242. PubMed ID: 37307878
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid cancer.
    Wu S; Liu Y; Li K; Liang Z; Zeng X
    J Mol Diagn; 2023 Aug; 25(8):569-582. PubMed ID: 37236546
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype.
    Zhou J; Wang WR; Zhang HF; Gao QQ; Wang WB; Zhu JH; Han YS; Chen J; Ma TH; Zhang XY; Teng XD
    Front Endocrinol (Lausanne); 2023; 14():1138100. PubMed ID: 37124750
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
    Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
    Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.
    Lee SE; Lee MS; Bang H; Kim MY; Choi YL; Oh YL
    Mod Pathol; 2023 Aug; 36(8):100180. PubMed ID: 37003481
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-ntrk3 positive metastatic salivary secretory carcinoma: A case series.
    Yokota T; Yukino H; Doi M; Ohori H
    Head Neck; 2023 May; 45(5):E10-E15. PubMed ID: 36924196
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Approaches to the diagnosis of secretory carcinoma of the salivary glands: a case series and review.
    Hermann CR; Gama-Cuellar AG; Díaz KP; Gondak R
    Gen Dent; 2023; 71(2):23-27. PubMed ID: 36825969
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.